MYOG and sarcoma: Given the expression of smooth muscle actin in the tumor cells, we entertained the possibility of a cutaneous myoid/myogenic sarcoma with aberrant cytokeratin expression, but additional myogenic markers including smooth muscle heavy chain myosin (SMMS), H‐caldesmon, desmin, and myogenin were negative, significantly diminishing that diagnostic consideration.